Menu

• Ask a Health Expert about CHRONIC LYMPHOCYTIC LEUKAEMIA
• Post Your Side Effect related to CHRONIC LYMPHOCYTIC LEUKAEMIA
• CHRONIC LYMPHOCYTIC LEUKAEMIA and FDA Warnings
• CHRONIC LYMPHOCYTIC LEUKAEMIA in Patients Wiki
• Report CHRONIC LYMPHOCYTIC LEUKAEMIA in Drug Side Effect Survey

CHRONIC LYMPHOCYTIC LEUKAEMIA side effect

What is CHRONIC LYMPHOCYTIC LEUKAEMIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Arava Side Effects Report #5654761-4
Consumer or non-health professional from GERMANY reported ARAVA problem on Mar 05, 2008. Female patient, 64 years of age, was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . ARAVA dosage: unknown. Patient recovered.

Raptiva Side Effects Report #5655649-5
RAPTIVA problem was reported by a Physician from SWITZERLAND on Feb 22, 2008. Male patient was diagnosed with psoriasis, blood cholesterol increased, inflammation, hypertension and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . RAPTIVA dosage: 0.74 ML, SINGLE. During the same period patient was treated with LIPITOR, MOBIC, COVERSYL. Patient recovered.

Leponex Side Effects Report #5661612-0
Physician from FRANCE reported LEPONEX problem on Mar 06, 2008. Female patient, 60 years of age, weighting 158.7 lb, was diagnosed with schizophrenia and was treated with LEPONEX. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, leukocytosis, lymphadenopathy, lymphocyte count increased, . LEPONEX dosage: 500 MG/DAY. During the same period patient was treated with ZOLOFT, HAVLANE, TRIMEPRAZINE, DAFLON. Patient recovered.

Tysabri Side Effects Report #5664286-8
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2008. Female patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with TEGRETOL, ADDERALL, KLONOPIN, COZAAR, PROZAC, LIDODERM, BACLFOEN PUMP, LYRICA. Patient recovered.


Tysabri Side Effects Report #5691298-0
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Mar 20, 2008. Female patient, 61 years of age, weighting 135.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, fatigue, hepatosplenomegaly, lymphadenopathy, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with TEGRETOL, ADDERALL, KLONOPIN, COZAAR, PROZAC, LIDODERM, BACLOFEN, LYRICA. Patient recovered.

Betaseron Side Effects Report #5610507-7
BETASERON problem was reported by a Physician from SWITZERLAND on Jan 30, 2008. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with multiple sclerosis, unevaluable event and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . BETASERON dosage: unknown. During the same period patient was treated with SIRDALUD. Patient recovered.

Rituxan Side Effects Report #5611670-4
Health Professional from UNITED KINGDOM reported RITUXAN problem on Jan 22, 2008. Male patient, 78 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, hepatic cirrhosis, infusion related reaction, . RITUXAN dosage: 375 MG/M2, UNK. During the same period patient was treated with ALLOPURINOL, ACETAMINOPHEN, DIPHENHYDRAMINE. Patient was hospitalized. Patient died.

Remicade Side Effects Report #5622125-5
REMICADE problem was reported by a Physician from SPAIN on Jan 31, 2008. Male patient, 72 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, thrombotic thrombocytopenic purpura, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLIC ACID, DEZACOR. Patient recovered.

Revlimid Side Effects Report #5637811-0
Physician from UNITED STATES reported REVLIMID problem on Feb 11, 2008. Male patient, 74 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, red blood cell count decreased, . REVLIMID dosage: unknown. Patient was hospitalized. Patient recovered.


Tysabri Side Effects Report #5638203-0
TYSABRI problem was reported by a Health Professional from UNITED STATES on Feb 12, 2008. Male patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . TYSABRI dosage: unknown. Patient recovered.

Avonex Side Effects Report #5643171-1
Health Professional from CANADA reported AVONEX problem on Feb 14, 2008. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . AVONEX dosage: unknown. Patient recovered.

Tysabri Side Effects Report #5592797-2
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Male patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . TYSABRI dosage: unknown. Patient recovered.

Betaseron Side Effects Report #5593064-3
Physician from SWITZERLAND reported BETASERON problem on Jan 10, 2008. Male patient, 57 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . BETASERON dosage: unknown. Patient recovered.

Avonex Side Effects Report #5605417-5
AVONEX problem was reported by a Health Professional from UNITED STATES on Jan 10, 2008. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . AVONEX dosage: unknown. Patient recovered.


Revlimid Side Effects Report #5614665-X
Physician from UNITED STATES reported REVLIMID problem on Jan 24, 2008. Male patient, 51 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, malignant neoplasm progression, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/07/2008.

Enbrel Side Effects Report #5536832-6
ENBREL problem was reported by a Physician from UNITED STATES on Mar 22, 2007. Male patient, weighting 186.1 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . ENBREL dosage: unknown. During the same period patient was treated with REMICADE. Patient recovered.

Lansoprazole Side Effects Report #5553629-1
Consumer or non-health professional from UNITED KINGDOM reported LANSOPRAZOLE problem on Dec 04, 2007. Female patient, 65 years of age, was diagnosed with schizophrenia and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, haemoglobin decreased, lymphocyte count increased, overweight, white blood cell count increased, . LANSOPRAZOLE dosage: unknown. During the same period patient was treated with CLOZARIL. Patient recovered.

Revlimid Side Effects Report #5565038-X
REVLIMID problem was reported by a Health Professional from UNITED STATES on Dec 07, 2007. Female patient, 77 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, malignant neoplasm progression, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 07/01/2007.

Revlimid Side Effects Report #5567841-9
Physician from UNITED STATES reported REVLIMID problem on Dec 11, 2007. Male patient, 71 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, malignant neoplasm progression, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 10/24/2007.


Natalizumab Side Effects Report #5580915-1
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Male patient was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . NATALIZUMAB dosage: unknown. Patient recovered.

Revlimid Side Effects Report #5510620-9
Physician from UNITED STATES reported REVLIMID problem on Nov 01, 2007. Female patient, 68 years of age, was diagnosed with lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, dehydration, dyspnoea, failure to thrive, hyperhidrosis, malignant neoplasm progression, oral intake reduced, . REVLIMID dosage: 5MG FOR 7DAYS, 10MG FOR 7 DAYS, 15MG FOR 7 DAYS, AND 20MG FOR 7 DAYS, DAILY, ORAL. Patient was hospitalized. Patient died on 08/01/2007.

Natalizumab Side Effects Report #5510878-6
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Oct 23, 2007. Female patient, 60 years of age, weighting 151.0 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, early satiety, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with SYNTHROID, DITROPAN, MOTRIN, VITAMIN B CAP. Patient recovered.

Natalizumab Side Effects Report #5450881-8
Physician from UNITED STATES reported NATALIZUMAB problem on Aug 27, 2007. Male patient, 46 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient recovered.

Natalizumab Side Effects Report #5479054-X
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Sept 25, 2007. Female patient, 60 years of age, weighting 151.0 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, early satiety, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with SYNTHROID, DITROPAN, MOTRIN, VITAMIN B CAP. Patient recovered.

Revlimid Side Effects Report #5479102-7
Pharmacist from UNITED STATES reported REVLIMID problem on Sept 28, 2007. Female patient, 69 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, malignant neoplasm progression, . REVLIMID dosage: 10 MG, QD, ORAL. Patient died on 01/01/2007.

Lansoprazole Side Effects Report #5489048-6
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 09, 2007. Female patient, 65 years of age, was diagnosed with schizophrenia and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, haemoglobin decreased, lymphocyte count increased, overweight, white blood cell count increased, . LANSOPRAZOLE dosage: unknown. During the same period patient was treated with CLOZARIL. Patient recovered.

Remicade Side Effects Report #5489332-6
Physician from JAPAN reported REMICADE problem on Oct 10, 2007. Male patient, 71 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.

Gleevec Side Effects Report #5501446-0
GLEEVEC problem was reported by a Health Professional from SWEDEN on Oct 22, 2007. Female patient was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, white blood cell count increased, . GLEEVEC dosage: 400 MG/D. Patient recovered.

Revlimid Side Effects Report #5452215-1
Physician from UNITED STATES reported REVLIMID problem on Sept 06, 2007. Female patient, 68 years of age, was diagnosed with lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, dehydration, dyspnoea, failure to thrive, hyperhidrosis, malignant neoplasm progression, oral intake reduced, . REVLIMID dosage: 5MG FOR 7DAYS, 10MG FOR 7DAYS, 15MG FOR 7 DAYS, AND 20MG, FOR 7 DAYS, DAILY, ORAL. Patient was hospitalized. Patient died on 01/01/2007.

Revlimid Side Effects Report #5463806-6
REVLIMID problem was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, 68 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, multi-organ failure, neutropenia, non-hodgkin's lymphoma, pyrexia, transfusion, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 06/28/2007.

Revlimid Side Effects Report #5465476-X
Physician from UNITED STATES reported REVLIMID problem on Sept 06, 2007. Female patient, 68 years of age, was diagnosed with lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, dehydration, dyspnoea, failure to thrive, hyperhidrosis, malignant neoplasm progression, oral intake reduced, . REVLIMID dosage: 5MG FOR 7 DAYS, 10MG FOR 7 DAYS, AND 20 MG FOR DAYS, DAILY, ORAL. Patient was hospitalized. Patient died on 01/01/2007.

Revlimid Side Effects Report #5472255-6
REVLIMID problem was reported by a Health Professional from UNITED STATES on Sept 21, 2007. Male patient, 65 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, malignant neoplasm progression, sepsis, systemic inflammatory response syndrome, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with IMMUNOGLOBULIN. Patient died on 05/17/2007.

Revlimid Side Effects Report #5472258-1
Physician from UNITED STATES reported REVLIMID problem on Sept 21, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia, myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, condition aggravated, . REVLIMID dosage: 5 MG, ORAL. Patient recovered.

Natalizumab Side Effects Report #5407191-4
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on July 23, 2007. Female patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with TEGRETOL, ADDERALL, KLONOPIN, COZAAR, PROZAC, LIDODERM, BACLOFEN, LYRICA. Patient recovered.

Endoxan Side Effects Report #5416504-9
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Aug 06, 2007. Female patient, 68 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, endometrial cancer, . ENDOXAN dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

Lamictal Side Effects Report #5418236-X
LAMICTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Female patient, 60 years of age, was diagnosed with depression and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, fatigue, lymphadenopathy, rash, . LAMICTAL dosage: 25MG PER DAY. During the same period patient was treated with ATIVAN, CELEXA. Patient recovered.

Epirubicin Side Effects Report #5418975-0
Health Professional from FRANCE reported EPIRUBICIN HYDROCHLORIDE problem on Aug 07, 2007. Female patient was diagnosed with breast cancer and was treated with EPIRUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, neoplasm malignant, . EPIRUBICIN HYDROCHLORIDE dosage: DAILY DOSE:85MG-FREQ:CYCLIC. During the same period patient was treated with FLUOROURACIL, ENDOXAN, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5421089-7
REVLIMID problem was reported by a Physician from UNITED STATES on Aug 14, 2007. Female patient, 52 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, malignant neoplasm progression, renal failure chronic, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 06/07/2007.

Revlimid Side Effects Report #5422052-2
Physician from UNITED STATES reported REVLIMID problem on Aug 09, 2007. Male patient, 50 years of age, weighting 331.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, lymphadenopathy, tonsillar hypertrophy, tumour flare, . REVLIMID dosage: 25 MG, DAILY ON DAYS 1-21, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Clozaril Side Effects Report #5389817-7
CLOZARIL problem was reported by a Health Professional from UNITED STATES on July 09, 2007. Male patient was diagnosed with affective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . CLOZARIL dosage: 300 MG, QD. Patient recovered.

Clozaril Side Effects Report #5389817-7
Health Professional from UNITED STATES reported CLOZARIL problem on July 09, 2007. Male patient was diagnosed with affective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . CLOZARIL dosage: 300 MG, QD. Patient recovered.

Remicade Side Effects Report #5759806-9
REMICADE problem was reported by a Physician from JAPAN on May 27, 2008. Male patient, weighting 165.3 lb, was diagnosed with rheumatoid arthritis, hypertension, asthma and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . REMICADE dosage: unknown. During the same period patient was treated with RHEUMATREX, RIMATIL, LOXONIN, AMLODIPINE, HOKUNALIN TAPE, CLARITHROMYCIN, MUCOSOLVAN. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5762059-9
Health Professional from CANADA reported AVONEX problem on May 20, 2008. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . AVONEX dosage: unknown. Patient recovered.

Revlimid Side Effects Report #5774828-X
REVLIMID problem was reported by a Physician from UNITED STATES on June 05, 2008. Male patient, 65 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, disease progression, . REVLIMID dosage: 10 MG, QD X21 DAYS, ORAL. Patient died on 05/10/2008.

Clozapine Side Effects Report #5788797-X
Health Professional from FRANCE reported CLOZAPINE problem on June 17, 2008. Male patient was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, lymphocytosis, . CLOZAPINE dosage: unknown. During the same period patient was treated with LEPTICUR, ATARAX, THERALENE, ZOLOFT, SOLIAN, ZOLPIDEM TARTRATE. Patient recovered.

Remicade Side Effects Report #5793103-0
REMICADE problem was reported by a Physician from JAPAN on June 18, 2008. Male patient, weighting 165.3 lb, was diagnosed with rheumatoid arthritis, hypertension, asthma and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . REMICADE dosage: unknown. During the same period patient was treated with RHEUMATREX, RIMATIL, LOXONIN, AMLODIPINE, HOKUNALIN TAPE, CLARITHROMYCIN, MUCOSOLVAN. Patient was hospitalized. Patient recovered.

Raptiva Side Effects Report #5726349-8
Consumer or non-health professional from UNITED STATES reported RAPTIVA problem on Apr 28, 2008. Male patient, weighting 250.0 lb, was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, . RAPTIVA dosage: 1 MG/KG, 1/WEEK. Patient recovered.

Clozapine Side Effects Report #5728556-7
CLOZAPINE problem was reported by a Physician from FRANCE on Apr 28, 2008. Male patient, 56 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, lymphocyte count increased, neutrophil count decreased, . CLOZAPINE dosage: unknown. Patient recovered.

Clozapine Side Effects Report #5728650-0
Physician from FRANCE reported CLOZAPINE problem on Apr 28, 2008. Male patient, 50 years of age, was treated with CLOZAPINE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, lymphocyte count increased, neutrophil count decreased, . CLOZAPINE dosage: unknown. Patient recovered.

Fludarabine Side Effects Report #5728938-3
FLUDARABINE PHOSPHATE problem was reported by a Physician from UNITED KINGDOM on Apr 24, 2008. Male patient, 89 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, mass, metastases to lung, skin cancer, . FLUDARABINE PHOSPHATE dosage: unknown. Patient died.

Revlimid Side Effects Report #5729544-7
Physician from UNITED STATES reported REVLIMID problem on Apr 22, 2008. Male patient, 60 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, malignant neoplasm progression, pancytopenia, sepsis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 02/15/2008.